Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-17 Sale |
2023-03-21 7:16 pm |
KINETA INC. | KA | PHILIPS CRAIG W. President |
2,103 | $4.2566 | $8,952 | 100,249 (Indirect Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:15 pm |
KINETA INC. | KA | Kenny Pauline General Counsel & Secretary |
1,311 | $4.2566 | $5,580 | 17,806 (Direct) |
View |
2023-03-17 Sale |
2023-03-21 7:15 pm |
KINETA INC. | KA | Iadonato Shawn Chief Executive Officer |
2,699 | $4.2557 | $11,486 | 674,840 (Indirect Direct) |
View |
2022-12-30 Purchase |
2023-01-04 4:14 pm |
KINETA INC. | KA | Bartoszek Raymond J. Director |
7,001 | $6.225 | $43,581 | 795,416 (Indirect Direct) |
View |
2022-12-02 Sale |
2022-12-06 4:56 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Peters Richard President and CEO |
10,890 | $1.6913 | $18,418 | 90,028 (Direct) |
View |
2022-12-02 Sale |
2022-12-06 4:55 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Wyzga Michael D See Remarks |
3,116 | $1.6913 | $5,270 | 13,997 (Direct) |
View |
2022-12-02 Sale |
2022-12-06 4:52 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Epstein Marie Principal Accounting Officer |
1,976 | $1.691 | $3,341 | 8,883 (Direct) |
View |
2022-12-02 Sale |
2022-12-06 4:51 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Smith Devin Whittemore SVP and General Counsel |
3,116 | $1.691 | $5,269 | 13,961 (Direct) |
View |
2022-07-05 Sale |
2022-07-06 4:54 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Peters Richard President and CEO |
4,584 | $1.8491 | $8,476 | 100,918 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 9:49 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Epstein Marie Principal Accounting Officer |
1,806 | $1.1946 | $2,157 | 10,859 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 9:46 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Smith Devin Whittemore SVP and General Counsel |
2,923 | $1.1946 | $3,492 | 17,077 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 9:45 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Wyzga Michael D See Remarks |
2,887 | $1.1946 | $3,449 | 17,113 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 9:45 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Peters Richard President and CEO |
10,206 | $1.1946 | $12,192 | 105,502 (Direct) |
View |
2022-03-28 Sale |
2022-03-30 4:05 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Peters Richard President and CEO |
10,715 | $1.8455 | $19,775 | 115,708 (Direct) |
View |
2022-02-03 Sale |
2022-02-07 4:05 pm |
YUMANITY THERAPEUTICS INC. | YMTX | Mohsen Paulash Chief Business Officer |
1,958 | $1.83 | $3,583 | 59,135 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-12 Option Award |
2023-04-14 4:06 pm |
N/A 2033-04-11 |
KINETA INC. | KA | Arkowitz David Director |
32,500 | $0 | 32,500 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:59 pm |
N/A 2028-11-09 |
KINETA INC. | KA | PHILIPS CRAIG W. President |
265,010 | $0 | 273,668 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:59 pm |
N/A N/A |
KINETA INC. | KA | PHILIPS CRAIG W. President |
8,658 | $11.55 | 273,668 (Indirect) |
View |
2022-12-16 Tax Withholding |
2022-12-20 8:59 pm |
N/A N/A |
KINETA INC. | KA | Peters Richard Director |
1,931 | $1.86 | 88,097 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:58 pm |
N/A 2023-12-31 |
KINETA INC. | KA | Kenny Pauline General Counsel |
61,082 | $0 | 64,522 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:57 pm |
N/A 2028-11-09 |
KINETA INC. | KA | Iadonato Shawn Chief Executive Officer |
910,373 | $0 | 919,031 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:57 pm |
N/A N/A |
KINETA INC. | KA | Iadonato Shawn Chief Executive Officer |
8,658 | $11.55 | 919,031 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:56 pm |
N/A 2032-05-30 |
KINETA INC. | KA | Guillaudeux Thierry Chief Scientific Officer |
28,207 | $0 | 38,527 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:56 pm |
N/A 2028-11-09 |
KINETA INC. | KA | Foote Marion R Director |
152,421 | $0 | 177,506 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:56 pm |
N/A N/A |
KINETA INC. | KA | Foote Marion R Director |
21,645 | $11.55 | 177,506 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:55 pm |
N/A 2031-05-26 |
KINETA INC. | KA | Bartoszek Raymond J. Director |
528,029 | $0 | 842,201 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 8:55 pm |
N/A N/A |
KINETA INC. | KA | Bartoszek Raymond J. Director |
375,757 | $11.55 | 842,201 (Indirect) |
View |
2022-12-16 Option Award |
2022-12-20 8:54 pm |
N/A 2032-10-19 |
KINETA INC. | KA | Baker Keith Chief Financial Officer |
20,640 | $0 | 20,640 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Verma Ajay EVP, Head of R&D |
30,000 | $0 | 30,200 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Epstein Marie Principal Accounting Officer |
12,665 | $0 | 12,665 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Wyzga Michael D See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Mohsen Paulash Chief Business Officer |
20,000 | $0 | 61,093 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Peters Richard President and CEO |
70,000 | $0 | 126,423 (Direct) |
View |
2021-12-01 Option Award |
2021-12-03 4:15 pm |
N/A N/A |
YUMANITY THERAPEUTICS INC. | YMTX | Smith Devin Whittemore SVP and General Counsel |
20,000 | $0 | 20,000 (Direct) |
View |
2021-11-11 Option Award |
2021-11-15 08:00 am |
2021-11-11 2031-04-12 |
YUMANITY THERAPEUTICS INC. | YMTX | Verma Ajay EVP, Head of R&D |
5,000 | $0 | 5,000 (Direct) |
View |
2021-08-16 Option Award |
2021-08-17 5:22 pm |
N/A 2031-08-15 |
YUMANITY THERAPEUTICS INC. | YMTX | Wyzga Michael D See Remarks |
65,000 | $0 | 65,000 (Direct) |
View |